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Neural progenitor cells (NPCs) are suggested to be a valuable source of cell transplant in treatment of various 
neurological diseases because of their distinct attributes. They can be expanded and induced to differentiate in 
vitro. However, it remains uncertain whether in vitro expanded NPCs have the capacity to give rise to func-
tional motoneurons after transplantation in vivo. Here, we showed that in vitro expanded NPCs, when trans-
planted into the musculocutaneous nerve, generated motoneuron-like cells that exhibited typical morphology 
with large cell bodies, expressed specific molecules, and extended axons to form functional connections with 
the target muscle. In contrast, transplanted NPCs failed to yield motoneurons in the injured ventral horn of the 
spinal cord. The results of the study demonstrate that NPCs have the potential to generate functional motoneu-
rons in an appropriate environment. The distinct differentiating fate of NPCs in the musculocutaneous nerve 
and the injured ventral horn suggests the importance and necessity of modifying the host microenvironment in 
use of NPCs for cell replacement therapies for motoneuron diseases.
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INTRODUCTION
Since the success in isolating and expanding neu-
ral progenitor cells (NPCs) from specific regions of 
the developing and adult CNS (19,22,24,25,34), NPCs 
have been widely used in neurological disorder repair. 
Compared to other stem cells, NPCs are already com-
mitted to a neural fate and hence will be easier to dif-
ferentiate into mature neural phenotypes (1). They are 
expected to replace lost, damaged, or dysfunctional neu-
rons in cell-based therapies for the treatment of a vari-
ety of neurological diseases such as Parkinson’s disease, 
Alzheimer’s disease, Huntington’s disease, amyotrophic 
lateral sclerosis (ALS), etc. However, many studies have 
reported that grafted NPCs differentiate predominantly 
into glial phenotypes and show very limited ability to 
produce region-specific neuronal phenotypes in the adult 
CNS (3,8,11,28,35).
The unfavorable environment of adult CNS is con-
sidered one of the factors responsible for the failure 
of grafted NPCs to generate region-specific neurons. 
An alternative explanation, however, is that in vitro 
expanded NPCs may lose the ability to respond to cues 
for regional specification (14,31). They are supposed 
to have limited plasticity and unable to give rise to 
region-specific neurons. Motoneuron diseases such as 
ALS, spinal bulbar muscular atrophy (SBMA), spinal 
muscular atrophy (SMA), and spinal muscular atrophy 
with respiratory distress 1 (SMARD1) are characterized 
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by degeneration of motoneurons, with resulting muscle 
wasting and paralysis. The selective degeneration of 
motoneurons is encouraging for cell replacement strat-
egies using stem cell-derived motoneurons (13). The 
usefulness of NPCs would be vastly limited for replace-
ment strategies for the treatment of motoneuron diseases 
if they are inherently unable to generate the projecting 
cells, although they are easy to be manipulated and 
propagated in large quantities. 
In the present study, we transplanted spinal cord- 
derived NPCs into the injured ventral horn and the tran-
sected musculocutaneous nerve to investigate whether 
they could yield motoneurons after transplantation in 
vivo. Our study showed that NPCs, when transplanted 
into the musculocutaneous nerve, produced motoneuron-
like cells that exhibited typical morphology with large 
cell bodies, expressed specific molecules, and formed 
functional connections with the target muscle. In con-
trast, NPCs failed to generate motoneurons in the injured 
ventral horn of the spinal cord. Our results provide evi-
dence that NPCs have the potential to efficiently generate 
functional motoneurons in an appropriate environment, 
and the failure of motoneuron generation in the injured 
ventral horn suggests the importance and necessity of 
modifying the host microenvironment in use of NPCs for 
cell replacement therapies for motoneuron diseases.
MATERIALS AND METHODS
All surgical interventions and subsequent care and 
treatment were approved by the Committee on the Use of 
Live Animals for Teaching and Research of the University 
of Hong Kong.
Cell Isolation, Culture, and Characterization
Under sterile conditions, spinal cords from embry-
onic day 13.5 transgenic Sprague–Dawley rats express-
ing green fluorescent protein (GFP; “green rat” CZ-004; 
SLC, Shizuoka, Japan) were dissected out and prepared 
for stem cell culture following procedures described 
previously (27). Briefly, the spinal cord was separated 
from surrounding connective tissue. After peeling off the 
meninges, the cord was transferred into a 15-ml centri-
fuge tube containing stem cell culture medium (described 
below) and dissociated to a single-cell suspension by gen-
tle mechanical trituration through a fire-polished Pasteur 
pipette. The dissociated cells were filtered through a cell 
strainer (BD Falcon, San Jose, CA, USA) and plated 
onto dishes coated with poly-l-lysine (PLL) (13.3 μg/
ml; Sigma, St. Louis, MO, USA) and laminin (20 μg/ml; 
Sigma). Stem cell culture medium consisted of DMEM-
F12 (Gibco, Grand Island, NY, USA), bovine serum albu-
min (BSA) (1 mg/ml; Sigma), B27 (20 μl/ml; Invitrogen, 
Carlsbad, CA, USA), N2 (10 μl/ml; Invitrogen), basic 
fibroblast growth factor (bFGF) (20 ng/ml; Peprotech, 
Rocky Hill, NJ, USA), and Pen-Strep (100 IU/ml; 
Invitrogen). Cells were maintained in an incubator with a 
humidified atmosphere containing 5% CO2 at 37°C. The 
medium was changed every 2 days. At around 80% con-
fluence, cells were passaged at a ratio of 1:4 to 1:6 after 
initial plating. These subcultured cells were designated 
as “first passage” (P1). All experiments were carried out 
using P1 NPCs in this study.
For in vitro experiments, cultured cells on cover-
slips were fixed in 4% paraformaldehyde dissolved 
in 0.1 M phosphate buffer (PB) for 20 min. After sev-
eral washes with 0.01 M PBS, cells were processed for 
immunocytochemistry. The following primary antibodies 
were used to stain the cells: mouse anti-nestin antibody 
(1:200; Chemicon) for characterization of undifferenti-
ated NPCs; mouse anti-neuronal nuclei (NeuN) (1:200; 
Chemicon), mouse anti-neurofilament 200 (NF200) 
(1:500; Chemicon), rabbit anti-choline acetyltransferase 
(ChAT) (1:200; Chemicon), and mouse anti-MAP2 
(1:400; Chemicon) for neurons; and rabbit anti-glial fibril-
lary acidic protein (GFAP) antibody (1:1,000; Sigma) 
and mouse anti-Rip antibody (1:50; a generous gift 
from Dr. X. M. Xu, University of Louisville, Kentucky, 
USA) for astrocytes and oliogodendrocytes, respectively. 
Cell slides were then counterstained with DAPI to stain 
nuclei and coverslipped with antifade mounting medium 
(FluorSave, Calbiochem). The images were taken with a 
laser confocal microscope (LSM510 META, Carl Zeiss 
Meditec, Jena, Germany).
Animal Surgery and Cell Transplantation
Thirty-two adult female Sprague–Dawley rats (220– 
250 g) were anesthetized with an intraperitoneal injec-
tion of ketamine (80 mg/kg) and xylazine (8 mg/kg). 
The animals were divided into two groups. The ani-
mals in the first group (n = 16) were subdivided evenly 
into two groups: one group received cell injection into 
both the root avulsion-injured ventral horn of the spi-
nal cord and the transected musculocutaneous nerve, 
and the other group received cell injection into the root 
avulsion-injured ventral horn only. Root avulsion was 
performed as described previously (29). Briefly, the rat 
was placed in a supine position, and the right seventh 
cervical (C7) spinal nerve of the brachial plexus was 
identified and isolated. Extravertebral avulsion was 
carried out by pulling the C7 spinal nerve out with a 
pair of microhemostatic forceps. The avulsed ventral 
and dorsal roots together with the dorsal root ganglia 
were cut away from the distal stump of the C7 spi-
nal nerve and examined under a microscope to con-
firm the success of the surgery. After root avulsion, 
the animals had the right musculocutaneous nerve 
isolated and then transected at the proximal site. One 
microliter of cell suspension was slowly injected into 
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the musculocutaneous nerve with a Hamilton syringe 
(needle gauge 30) with a sharpened tip. Immediately 
after cell transplantation into the musculocutaneous 
nerve, the same animal then received cell graft into the 
avulsed ventral horn. The dorsal neck musculature was 
incised, and a laminectomy was performed at C6. Under 
an operating microscope, a glass micropipette (100-μm 
outer diameter) connected to a Hamilton syringe was 
stereotactically advanced into the avulsed ventral horn 
(ML: −0.8 mm and DV: −1.5 mm from dura) at the right 
C7 spinal segment. One microliter of cell suspension 
was slowly injected over 5 min into the avulsed ventral 
horn. P1 NPCs derived from embryonic day 13.5 GFP 
rat spinal cords were dissociated and resuspended in 
NB medium at a concentration of 1.0 × 105 cells/μl and 
placed on ice for the duration of the grafting session. 
Cell viability was assessed with trypan blue at the end 
of transplantation, and typically more than 90% of the 
cells excluded the dye. In the second group, the animals 
were subdivided evenly into two groups: receiving 
either cell transplantation (n = 8) or vehicle injection 
(n = 8) into the transected musculocutaneous nerve. The 
dura was closed with 10–0 sutures, while muscle fascia 
were reapposed and sutured with 4–0 sutures, and the 
skin was closed with wound clips. In the control group, 
animals received an injection of the same volume of 
NB medium instead of cell suspension into the mus-
culocutaneous nerve and the avulsed ventral horn. The 
animals were kept warm and allowed to recover from 
anesthesia before being returned to their cages. All the 
animals were allowed to survive for 12 weeks.
Tissue Processing
At the end of the survival period, eight animals in the 
first group were killed with a lethal dose of sodium pen-
tobarbital and perfused intracardially with 0.01 M PBS 
(pH 7.4), followed by 200–300 ml of fixative solution 
containing 4% paraformaldehyde in 0.1 M PB (pH 7.4). 
The right musculocutaneous nerve and the C7 segments 
of spinal cords were harvested and fixed in fresh fixa-
tive solution overnight and subsequently placed in 30% 
sucrose–0.1 M PB at 4°C for 2–3 days. The C7 segments 
were then cut into 30-μm sections on a cryostat. The serial 
sections were collected in 0.01 M PBS and kept at 4°C for 
further study.
Immunohistochemistry
Longitudinal nerve sections and cross spinal cord 
sections were collected for immunostaining. Sections 
were washed in 0.01 M PBS, blocked in 10% goat 
serum for 1 h, and incubated with primary antibodies 
at 4°C overnight. Neurons were detected with mouse 
anti-neuronal nuclei (NeuN) (1:200; Chemicon), mouse 
anti-neurofilament 200 (NF200) (1:500; Chemicon), and 
rabbit anti-choline acetyltransferase (ChAT) (1:200; 
Chemicon); astroglial cells were identified using rab-
bit anti-glial fibrillary acidic protein (GFAP) (1:1,000; 
Sigma); myelinating cells were identified using mouse 
anti-adenomatus polyposis coli (APC) (1:200; BD 
Biosciences Pharmingen, San Jose, CA, USA), S-100b 
(1:200; BD Biosciences Pharmingen), and myelin basic 
protein (MBP) (1:500; BD Biosciences Pharmingen); 
rabbit anti-GFP (1:800; Abcam) was used to intensify 
the GFP signal. Sections were washed in 0.01 M PBS, 
and species-specific fluorescence-conjugated secondary 
antibodies (goat anti-mouse or anti-rabbit) conjugated 
to Alexa 568 (1:400; Molecular Probes) were applied 
for 2 h at 20°C. After being washed in 0.01 M PBS, 
sections were then counterstained with 4′,6-diamidino-
2-phenylindole (DAPI) to stain nuclei and cover-
slipped with antifade mounting medium (FluorSave, 
Calbiochem, San Diego, CA, USA). To assess differ-
entiation patterns of transplanted cells, we stained two 
tissue sections per rat (eight animals in each group) for 
each cell marker and then counted the number of GFP-
expressing cells colocalized with the cell marker in 10 
random fields per section at 40× magnification using 
a confocal microscope (LSM510 META, Carl Zeiss 
Meditec, Jena, Germany). On average, around 200 cells 
were counted per section. All quantification was per-
formed in an unbiased stereological manner.
Electromyographic Measurements
At the end of the study, the animals in the second group 
were killed (eight animals from the cell implantation group 
and eight from the vehicle control group), and the muscu-
locutaneous nerve and biceps brachii muscle were quickly 
removed and transferred into a recording chamber that was 
continuously perfused with room-temperature oxygenated 
Tyrode’s solution (125 mM NaCl, 24 mM NaHCO3, 5.4 mM 
KCl, 1 mM MgCl2, 1.8 mM CaCl2, and 5% dextrose) at a 
flow rate of 4–5 ml/min. Electromyographic (EMG) record-
ings were obtained using a suction electrode on the surface 
of the muscle, while a second suction electrode was used 
to stimulate the nerve. EMG signals were amplified with 
a differential amplifier (EX4-400, Dagan), captured using 
Axoscope 9.2 software (Molecular Devices). To confirm 
that the muscle contractions resulted from neurotransmis-
sion by graft-derived motoneurons, the competitive nico-
tinic antagonist d-tubocurarine (Research Biochemicals 
International) was applied to the recording solution. EMG 
activity was recorded with d-tubocurarine and after a 5-h 
washout period.
Neuromuscular Junction Labeling
Wet weight of the biceps brachii muscle was mea-
sured and compared between the cell transplant and con-
trol groups. The musculocutaneous nerve and the biceps 
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brachii muscle were then fixed in 3.7% formaldehyde and 
cryosectioned at 30 μm. The nerve sections were used for 
immunohistological and EM studies. Biceps brachii muscle 
slices were incubated with 1 μg/ml rhodamine-conjugated 
a-bungarotoxin (a-BT; 1:400; Molecular Probes) for 1 h 
at room temperature to visualize acetylcholine receptors 
(ACHRs). The muscle slices were then immunostained 
with NF200 to label nerve terminals. 
Immunoelectron Microscopy
Cryostat nerve sections were processed for immunoelec-
tron microscopy to study the myelination of axons extending 
Figure 1. P1 neural progenitor cell (NPC) characterization and differentiation pattern in vitro. (A) P1 NPCs were plated as a monolayer on 
poly-l-lysine (PLL)/laminin-coated culture dishes in basic fibroblast growth factor (bFGF)-supplemented culture medium. The green fluo-
rescent protein (GFP)-positive cells showed a bipolar or multipolar morphology with round-shaped cell bodies (A1). Immunocytochemistry 
of these cells revealed efficient expression of the progenitor cell marker nestin (A2). The majority of the GFP-expressing cells were 
nestin positive (A3). (B) Microtubule-associated protein 2 (MAP2) staining showed that less than 1% cells in P1 NPC culture were posi-
tive (0.96 ± 0.1%). (C) No neurofilament 200 (NF200)-positive cells were found in the culture. (D) No choline acetyltransferase (ChAT)-
positive cells were found in the culture. (E) No neuronal nuclei (NeuN)-positive cells were found in the culture. (F–I) When bFGF was 
removed from the culture and replaced with 1% fetal bovine serum (FBS) for 5 days, a number of NPCs (16.7%) differentiated into MAP2-
positive neurons (F). The majority of NPCs (73.5%) differentiated into glial fibrillary acidic protein (GFAP)-positive astrocytes (H), and a 
small population of NPCs (8.4%) into Rip-positive oligodendrocytes (I). However, no ChAT-positive cells were found in the culture (G). 
(J) Percentage of ICC-positive cells presented as mean ± SEM (ICC, immunocytochemistry). Scale bars: 80 μm.
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from graft-derived neurons. Sections were incubated with 
mouse anti-NF200 (1:500; Chemicon) at 4°C overnight, 
followed by biotinylated anti-mouse IgG antibody (1:400; 
Chemicon). After being washed, sections were soaked 
for 1 h with an avidin–peroxidase complex (ABC Elite, 
Vector, Burlingame, CA) according to the manufacturer’s 
suggestion and then reacted with diaminobenzidine for 
5 min. The reaction was stopped by washing extensively in 
PBS. After osmication in 1% OsO4 for 1 h, sections were 
washed again in 0.1 M PB buffer, dehydrated through an 
ascending alcohol series ending in propylene oxide, and 
subsequently embedded using Eponate 12 Kit (Ted Pella, 
Redding, CA). Then, semithin sections were cut at 1 μm, 
mounted on glass slides, and stained with toluidine blue 
or Richardon’s stain. Ultrathin sections were cut at 60 nm 
on a Reichert Ultracut S microtome (Leica); mounted on 
nickel grids, uranyl acetate, and lead citrate stained; and 
viewed under a Philips TEM/CM 10 electron microscope.
Statistics Analysis
Data were collected and expressed as mean ± SEM. 
Student’s two-tailed t test was used for comparison of two 
experimental groups. Changes were identified as signifi-
cant if p < 0.05.
RESULTS
In Vitro Characterization of NPCs (Fig. 1) 
To characterize P1 NPCs before transplantation, dis-
sociated cells in single-cell suspension were plated onto 
coverslips coated with PLL/laminin (1:1 ratio) at a density 
of 104/cm2 on a 24-well plate. With bFGF-supplemented 
culture medium, nearly all the cells showed a bipolar or 
multipolar morphology with small cell bodies and were 
immunoreactive for nestin, a marker for NPCs (Fig. 1A, J). 
MAP2 staining showed that less than 1% cells were posi-
tive (0.96 ± 0.1%; Fig. 1B, J). Neither NF200-positive 
cells nor ChAT-positive cells were found in the culture 
Figure 2. Neuronal differentiation of NPCs at 12 weeks after transplantation into the acutely avulsed ventral horn. (A) A cross section with 
NeuN staining shows the presence of motoneurons with large cell bodies in the normal ventral horn. (B) A cross section with NeuN staining 
shows the loss of motoneurons in the avulsed ventral horn. (C1–C3) A small proportion of grafted NPCs differentiated into NeuN-positive 
cells in the ventral horn. (D) Higher magnification of the outlined area in (C3). Some grafted cells with weaker intensity of GFP (arrow) in the 
ventral horn (D1) coexpressed NeuN (D2, D3). (E) Percentage of NeuN-positive neurons presented as mean ± SEM. Scale bars: 50 μm.
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(Fig. 1C, D, J). NeuN staining showed that no cells were 
NeuN positive in the culture (Fig. 1E, J). These data 
confirmed that the cells remained at an immature stage. 
When bFGF was replaced with 1% fetal bovine serum 
(FBS), the NPCs began to differentiate. At the fifth 
day of culture with this differentiating medium, around 
16.7% of the NPCs differentiated into MAP2-positive 
neurons (Fig. 1F, J). However, no NPCs were found 
to differentiate into ChAT-positive neurons in the in vitro 
differentiation system (Fig. 1G, J). The majority of NPCs 
differentiated into glial cells after 5 days in differentiating 
medium, with 73.5% differentiating into GFAP-positive 
astrocytes (Fig. 1H, J) and 8.4% into Rip-positive oligoden-
drocytes (Fig. 1I, J).
Grafted NPCs Failed to Generate Motoneuron-Like 
Cells in the Acutely Avulsed Ventral Horn
Avulsion injury leads to massive motoneuron death 
in the ventral horn. NeuN staining demonstrated that, com-
pared to the normal (Fig. 2A), massive neuronal loss was 
found in the avulsed ventral horn (Fig. 2B). To investi-
gate whether grafted NPCs could respond to environ-
mental cues to differentiate into motoneuron-like cells 
in the avulsed ventral horn, we performed immunohis-
tochemical analyses at 12 weeks after transplantation. 
Transplanted NPCs were easily detected based on GFP 
expression. Cross sections of spinal cords from animals 
at 12 weeks after cell transplantation following root avul-
sion showed that the transplanted cells survived robustly 
in the avulsed ventral horn (Fig. 2C). NeuN staining 
revealed that only a small proportion of the grafted NPCs 
(5.1 ± 1.6%) differentiated into NeuN-positive cells, 
which were predominantly confined to the injection site in 
the ventral horn (Fig. 2C–E). These graft-derived neurons 
were much smaller in size compared to the host motoneu-
rons (Fig. 2A). The intensity of GFP in NeuN-positive 
cells was much weaker than that in NeuN-negative cells 
(Fig. 2D). This seems to indicate that grafted NPCs 
Figure 3. NPCs failed to differentiate into ChAT-positive neurons at 12 weeks after transplantation 
into the acutely avulsed ventral horn. (A) A cross section with ChAT staining showed the presence 
of ChAT-positive motoneurons in the normal ventral horn. (B) A cross section with ChAT staining 
showed complete loss of ChAT-positive neurons in the avulsed ventral horn. (C) A cross section with 
ChAT staining demonstrated that no graft-derived ChAT-positive cells were observed in the avulsed 
ventral horn. (D) Higher magnification of an area of interest in (C), further showing that no grafted 
cells colabeled with GFP and ChAT. Scale bars: 70 μm.
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down-regulated GFP expression after differentiation into 
neuron-like cells. ChAT is an enzyme that catalyzes ace-
tylcholine synthesis for signal conduction through the 
neuromuscular junctions and is specifically expressed in 
motoneurons in the ventral horn. ChAT-positive motoneu-
rons were present in the ventral horn of the normal side, 
showing typical motoneuron morphology with large cells 
bodies (Fig. 3A). Root avulsion led to a complete loss 
of host ChAT-positive cells in the injured ventral horn 
(Fig. 3B). Transplanted NPCs failed to generate ChAT-
positive neurons as demonstrated by the lack of positive 
staining for ChAT in the cell graft in the avulsed ven-
tral horn (Fig. 3C, D). Similar to ChAT staining, NF200 
staining did not detect any graft-derived NF200-positive 
cells in the ventral horn at 12 weeks after transplantation 
(data not shown).
Grafted NPCs Generated Motoneuron-Like Cells  
in the Transected Musculocutaneous Nerve
We then investigated the differentiation pattern of NPCs 
in the peripheral nerve. Immunostaining with a package 
of neuronal markers showed that the transected nerve is 
much more favorable for grafted NPCs to differentiate 
into neurons than the injured ventral horn of spinal cords. 
Substantial survival of GFP-expressing cells was observed 
in the musculocutaneous nerve at 12 weeks after transplan-
tation (Fig. 4). Approximately 30.6 ± 3.5% NPCs differen-
tiated into NeuN-positive cells in the musculocutaneous 
nerve at 12 weeks after transplantation, which is much 
higher than the 5.1 ± 1.6% graft-derived NeuN-positive 
cells found in the ventral horn of the same animal (Fig. 4). 
To confirm the favorable effects of peripheral nerve on neu-
ronal differentiation and to eliminate potential interactions 
between transplanted NPCs in the ventral horn and those 
in the peripheral nerve of the same animal, we transplanted 
NPCs into the single site of the animals (either the ven-
tral horn or the transected musculocutaneous nerve only). 
NeuN staining revealed similar results of neuronal dif-
ferentiation. Around 32.6 ± 5.6% and 4.8 ± 1.3% NPCs 
differentiated into NeuN-positive cells in the musculo-
cutaneous nerve and injured ventral horn of independent 
animals, respectively (data not shown). In contrast to no 
graft-derived NF200-positive staining in the injured ven-
tral horn (data not shown), nearly 18.7 ± 3.1% NPCs were 
Figure 4. Neuronal differentiation of NPCs at 12 weeks after transplantation into the transected mus-
culocutaneous (MC) nerve. (A) A longitudinal section of the nerve with NeuN staining shows that 
many grafted NPCs differentiated into NeuN-positive cells in the nerve. (B) Higher magnification of 
the outlined area in (A3). (C) Significantly more grafted NPCs differentiated into NeuN-positive neu-
rons in the MC nerve than in the avulsed ventral horn. Data are presented as mean ± SEM. *p < 0.001 
(Student’s t test). Scale bars: 35 μm.
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detected to differentiate into NF200-positive cells in the 
nerve at 12 weeks after transplantation (Fig. 5A, B, D). 
Notably, these graft-derived NF200-positive neurons in the 
musculocutaneous nerve had enormously large cell bodies, 
with a mean soma diameter of 22.8 ± 4.2 μm (Fig. 5B, C, E). 
On detailed examination under higher magnification, these 
cells exhibited extensive processes from their somato-
dendritic compartment (Fig. 5C). ChAT staining further 
demonstrated that NPCs were able to give rise to ChAT-
positive neurons in the musculocutaneous nerve (Fig. 6A). 
Around 19.2 ± 2.7% NPCs were found to be ChAT positive 
with large cell bodies (mean soma diameter, 17.6 ± 3.5 μm) 
at 12 weeks after transplantation (Fig. 6B, C).
We used a number of markers to examine the glial dif-
ferentiation of grafted NPCs in the nerve. GFAP stain-
ing showed that the majority of NPCs differentiated into 
GFAP-positive cells. Immunostaining with APC, MBP, 
or S-100b did not detect any positive staining in the cell 
graft, suggesting that NPCs failed to produce myelinat-
ing cells after transplantation into the nerve. We also 
investigated whether there were immature cells remain-
ing in the graft at 12 weeks after transplantation into the 
injured musculocutaneous nerve. Nestin staining showed 
that no positive cells were detected in the graft (data 
not shown), suggesting that all transplanted cells had 
differentiated in the nerve. By 12 weeks after transec-
tion, we examined axonal extension of graft-derived 
motoneuron-like cells in the musculocutaneous nerve 
(Fig. 7A). The longitudinal section of the nerve from 
the vehicle control animals was devoid of any NF200 
staining (Fig. 7B). However, NF200-labeled axons were 
present throughout the transected nerve from the cell-
Figure 5. NPCs generated NF200-positive neurons at 12 weeks after transplantation into the 
transected musculocutaneous nerve. (A) A longitudinal section of the nerve with NF200 staining 
shows that many grafted NPCs differentiated into NF200-positive cells in the nerve. (B) Higher mag-
nification of the outlined area in (A) showing graft-derived NF200-positive neurons with large cell 
bodies (arrow). (C) Under higher magnification, these cells exhibited extensive processes from their 
somatodendritic compartment. (D) Percentage of NF200-positive neurons presented as mean ± SEM. 
(E) Mean soma diameter (±SEM) of NF200-positive neurons. Scale bars: 75 μm.
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implanted animals (Fig. 7C). Using anti-GFP antibody 
to intensify GFP signal, these NF200-positive axons 
were clearly shown to be colabeled with GFP, suggest-
ing they were extending from the cell graft toward the 
nerve terminal (Fig. 7C). Immunoelectron microscopy 
showed the presence of Schwann cells in the nerve 
(Fig. 7D), and graft-derived axons were closely sur-
rounded by Schwann cells, suggesting the beginning of 
myelination (Fig. 7E).
Grafted NPCs Formed Functional Connections With 
Target Muscles and Reduced Denervated Muscle Atrophy
A definitive character of functional motoneurons is 
that they have the capacity to functionally innervate 
the target muscle. The rat musculocutaneous nerve and 
biceps brachii model allows us to assess the functional 
innervation of grafted cells by histological studies and 
electrophysiological analyses. Muscle wet weight analy-
sis showed that denervated biceps brachii muscle atro-
phied severely and its weight remained only one-fifth 
of the normal side at 12 weeks after transection of the 
musculocutaneous nerve (Fig. 8A, B). Transplantation 
of NPCs in the transected musculocutaneous nerve sig-
nificantly reduced the target muscle atrophy, in that the 
biceps brachii muscle weight of the cell-implanted ani-
mals retained nearly 50% of the normal side (Fig. 8A, B). 
Sections of the biceps brachii muscle exhibited many 
neuromuscular junctions in cell-implanted animals as 
identified by rhodamine-conjugated a-BT, and NF200-
positive axons were found to be in apposition to the 
neuromuscular junctions (Fig. 8C), whereas neither neu-
romuscular junctions nor NF200-positive axons were 
found in vehicle control animals (Fig. 8D). Figure 8E 
shows axon terminals attached to the neuromuscular 
junctions in the normal animals. When the peripheral 
nerve in isolated nerve–muscle preparations was stimu-
lated, successful EMG response was easily induced in 
normal animals (Fig. 8F), while no EMG response was 
found in vehicle control animals (Fig. 8G). Notably, suc-
cessful EMG response was also induced in all the ani-
mals with cell transplants (Fig. 8H1). To confirm that 
the muscle contractions resulted from neurotransmission 
by graft-derived motoneurons, the competitive nicotinic 
antagonist d-tubocurarine was applied to the recording 
solution. EMG activity was blocked with d-tubocurarine 
(Fig. 8H2), and this blockade was reversed after a 5-h 
washout period (Fig. 8H3). These data indicated func-
tional innervation into the biceps brachii by implanted 
NPC-derived motoneurons.
DISCUSSION
Stem cell-based replacement strategies hold great 
promise in the treatment of motoneuron diseases due to 
their ability to replace lost, damaged, or dysfunctional 
neurons (10,20). Using the rat brachial plexus injury 
model, we have demonstrated that spinal cord-derived 
NPCs, after transplantation in the transected musculo-
cutaneous nerve, efficiently generate functional moto-
neurons as evidenced by typical morphology, specific 
molecular expression, and the capacity to innervate target 
muscles. This study suggests that in vitro expanded NPCs 
have therapeutic potential in cell therapy for motoneuron 
diseases due to their capability to give rise to functional 
motoneurons after transplantation in vivo.
Figure 6. NPCs generated ChAT-positive neurons at 12 weeks after transplantation into the 
transected musculocutaneous nerve. (A) ChAT immunostaining of NPCs in the transected muscu-
locutaneous nerve. Arrows indicate colabeling of ChAT and GFP. (B) Percentage of ChAT-positive 
neurons presented as mean ± SEM. (C) Mean soma diameter (±SEM) of ChAT-positive neurons. 
Scale bars: 40 μm.
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It is still under consideration which stem cell type is 
the best source for treating specific neurological disor-
ders such as motoneuron diseases. A number of stud-
ies have reported on the use of embryonic stem cells 
(ESCs) as a cell source of motoneurons. Both murine 
and human ESCs have been proven to be able to dif-
ferentiate into functional motoneurons when exposed to 
Sonic Hedgehog (Shh) and retinoic acid (RA) (17,36). 
Spinally implanted ESC-derived motoneurons could 
survive in the ventral horn and extend axons into the 
ventral roots (6,9). However, immune rejection and 
ethical controversy are major hurdles for the clinical 
application of ESCs. In addition, the difficulty in the 
purification of directed cells and the risk of teratoma 
formation are other major concerns related to the use 
of ESCs.
Figure 7. Graft-derived motoneuron-like cells extended axons along the nerve. (A) A schematic figure showing cell injection into 
the musculocutaneous nerve (*transected site; rectangle, an area used for studies of axonal extension as revealed in B, C). (B) The 
longitudinal section of the nerve in the vehicle control animals was devoid of any GFP or NF200 staining. (C) The longitudinal sec-
tion of the nerve in the cell-implanted animals showed that NF200-labeled axons were present throughout the transected nerve. Using 
anti-GFP antibody to intensify GFP signal (C1), these NF200-positive axons were clearly shown to be colabeled with GFP (C2, C3). 
(D) An immunoelectron micrograph showing a motoneuron-like cell with two Schwann cell-like cells in the nerve. (E) An immu-
noelectron micrograph showing that graft-derived axons were closely surrounded by Schwann cells (a, axon; arrows, processes of 
Schwann cells; arrowheads, collagen fibers). Scale bars: 80 μm (B, C) and 2 μm (D, E).
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Induced pluripotent stem cells (iPSCs) have the 
advantage of eliminating immune rejection and ethi-
cal concerns because they are obtained from the host as 
well as have pluripotent behavior (30,37). Many stud-
ies have shown that iPSCs can successfully differenti-
ate into functional motoneurons, opening an avenue 
for the clinical application of iPSC technology in the 
future (2,7,12,16,26). However, there are a number of 
fundamental issues that need to be addressed on the use 
of iPSCs for neurological disorders, such as the low 
efficiency of neuronal differentiation with high variety 
across different iPS cell lines and the potential risks 
associated with transplantation of iPSC derivatives in 
vivo, such as carcinogenesis resulting either from over-
expression of the oncogene or from insertional muta-
genesis into the host genome.
NPCs are well recognized as a valuable source of cell 
transplant in the treatment of various neurological dis-
eases because of their distinct attributes: they are commit-
ted to neural lineages and never give rise to inappropriate 
cell types; they are easily maintainable and readily 
engraftable; they have apparent abilities to integrate with 
Figure 8. Grafted NPCs formed functional connections with the target muscle and reduced muscle atrophy. (A) Gross morphology of 
isolated musculocutaneous nerve and biceps brachii muscle at 12 weeks after cell or vehicle injection into the transected musculocu-
taneous nerve. Samples from an animal with cell graft (left), an animal with vehicle injection (middle), and a normal animal (right). 
(B) Transplantation of NPCs in the transected musculocutaneous nerve significantly reduced the target muscle atrophy compared to 
the vehicle control. *p < 0.001 (Student’s t test). (C) A cross section of biceps brachii muscle showing that axon terminals labeled with 
NF200 (green) were in apposition to the neuromuscular junctions [labeled with rhodamine-conjugated a-bungarotoxin (a-BT)] in the 
cell-grafted animals. (D) A cross section of biceps brachii muscle showing that neither neuromuscular junctions nor NF200-positive 
axons were found in the vehicle control animals. (E) A cross section of biceps brachii muscle showing axon terminals attached to 
the neuromuscular junctions in the normal animals. (F) Successful electromyographic (EMG) response was readily induced in the 
normal animals when the peripheral nerve in isolated nerve–muscle preparations was stimulated. (G) No EMG response was found in 
vehicle control animals. (H) Successful EMG response was induced in animals with cell transplants (H1); EMG response was medi-
ated through the neuromuscular junction, since application of d-tubocurarine effectively attenuated EMG activity (H2), which was 
recovered after a 5-h washout period (H3). Scale bars: 5 mm (A) and 100 μm (C–E).
2662 SU ET AL.
the host environment and develop into integral cyto-
architectural components of CNS. Root avulsion of the 
brachial plexus leads to massive motoneuron degenera-
tion and severe functional deficits (32). Transplantation 
of NPCs into the acutely avulsed ventral horn, however, 
failed to induce graft-derived motoneuron generation, 
suggesting that the environmental cues of the injured 
ventral horn are insufficient to induce NPCs to yield 
region-specific neurons for cell replacement. In contrast, 
when we transplanted NPCs into the transected muscu-
locutaneous nerve, NPCs successfully differentiated into 
functional motoneurons to innervate the target muscle, 
indicating that the nerve holds sufficient cues to drive 
NPCs to yield motoneuron-like cells. Schwann cells in 
the nerve and molecular signals from terminal myocytes 
may contribute to the permissive milieu for NPC differ-
entiation (33). The distinct differentiating fate of NPCs 
in the ventral horn and the peripheral nerve highlights the 
importance of host microenvironment affecting NPC dif-
ferentiation. Very recently, we have reported that NPCs 
transplanted only at 2 weeks postavulsion were able to 
differentiate into ChAT-positive neurons, whereas trans-
plantation immediately or at 6 weeks postavulsion did 
not induce NPCs to produce ChAT-positive neurons (28). 
The up-regulated expression levels of brain-derived neu-
rotrophic factor (BDNF) and glial derived neurotrophic 
factor (GDNF) in the ventral horn at 2 weeks postavul-
sion are supposed to be the possible factor for render-
ing it as a supportive milieu for NPC differentiation. 
This study further indicates that, using NPCs to treat 
motoneuron diseases, it is necessary to modify the CNS 
microenvironment, which favors grafted cells to differ-
entiate toward region-specific neurons.
The capacity of NPCs toward motoneuron differ-
entiation has been explored by a number of studies 
(4,5,15,18,21,23). However, all these studies did not 
investigate whether NPC-derived motoneurons could 
functionally innervate target muscles in vivo. Using the 
rat musculocutaneous nerve and biceps brachii model, we 
demonstrate that NPCs successfully generate functional 
motoneurons after transplantation in vivo. The model pro-
vides an excellent platform for us to evaluate the functional 
innervation of graft-derived motoneurons into the target 
muscle. Our study shows that in vitro expanded NPCs 
efficiently generate functional motoneurons, which extend 
axons to innervate the target muscle (biceps brachii) after 
transplantation into the transected musculocutaneous nerve 
and significantly reduce muscle atrophy. 
In summary, the present study provides convincing 
evidence that NPCs have the potential to generate func-
tional motoneurons in vivo, suggesting that NPCs could 
be a valuable cell source for the treatment of motoneuron 
diseases. The present study also highlights the importance 
of the future work to screen out the favorable molecules 
in the peripheral nerve and the inhibitory factors present 
in the ventral horn due to the distinct differentiating fate 
of NPCs in these two regions, which undoubtedly help us 
understand how to modify the host microenvironment to 
favor cell therapy.
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